These data, combined with the findings from the co-IP (Figures 1B–1C, 2D) and GST pull-down (Figure 2C) experiments, indicate that GPER interacts with NHERF1 in breast cancer cells and this interaction requires intact C-terminal of GPER. Here, NHERF1 is linked to breast carcinoma.